Breast Cancer - ER+, HER2-, PIK3CA Gene Mutation

Explore clinical trials studying Breast Cancer - ER+, HER2-, PIK3CA Gene Mutation. Study availability and eligibility vary by location and protocol.

2 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Breast Cancer - ER+, HER2-, PIK3CA Gene Mutation trial results

Not Yet Recruiting

NCT07387861

Conditions: Breast Cancer - ER+, HER2-, PIK3CA Gene Mutation, Breast Diseases, Breast Neoplasms, +4 more
Locations: Not specified

Completed

NCT02260661

Conditions: Advanced Solid Malignancies, Breast Cancer - ER+, HER2 -, Breast Cancer - ER+, HER2-, PIK3CA Gene Mutation, +6 more
Locations: Research Site Denver, Colorado, United States

Research Site Greenville, South Carolina, United States

Research Site Nashville, Tennessee, United States

Research Site Houston, Texas, United States